Abstract
In China, few molecular epidemiological data on hepatitis C virus (HCV) are available and all previous studies were limited by small sample sizes or specific population characteristics. Here, we report characterization of the epidemic history and transmission dynamics of HCV strains in China. We included HCV sequences of individuals belonging to three HCV surveillance programs: 1) patients diagnosed with HIV infection at the Beijing HIV laboratory network, most of whom were people who inject drugs and former paid blood donors, 2) men who have sex with men, and 3) the general population. We also used publicly available HCV sequences sampled in China in our study. In total, we obtained 1,603 Ns5b and 865 C/E2 sequences from 1,811 individuals. The most common HCV strains were subtypes 1b (29.1%), 3b (25.5%) and 3a (15.1%). In transmission network analysis, factors independently associated with clustering included the region (OR: 0.37, 95% CI: 0.19–0.71), infection subtype (OR: 0.23, 95% CI: 0.1–0.52), and sampling period (OR: 0.43, 95% CI: 0.27–0.68). The history of the major HCV subtypes was complex, which coincided with some important sociomedical events in China. Of note, five of eight HCV subtype (1a, 1b, 2a, 3a, and 3b), which constituted 81.8% HCV strains genotyped in our study, showed a tendency towards decline in the effective population size during the past decade until present, which is a good omen for the goal of eliminating HCV by 2030 in China.
Funder
China Capital's Funds for Health Improvement and Research
Beijing Municipal Science & Technology Commission
Cultivation Fund of Beijing Center for Disease Prevention and Control
Beijing High-Level Public Health Doctor Cultivation Project
Publisher
Public Library of Science (PLoS)
Reference46 articles.
1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modeling study;The Polaris Observatory HCV Collaborators;Lancet Gastroenterol Hepatol,2017
2. National Health Commission of the People’s Republic of China. An overview of the epidemic situation of legal infectious diseases in China in 2020.2021;http://http://www.nhc.gov.cn/jkj/s3578/202103/f1a448b7df7d4760976fea6d55834966.shtml.
3. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD 2017 Cirrhosis Collaborators;Lancet Gastroenterol Hepatol,2020